Bruker Posts 5 Percent Revenue Gain for Q2, Trims Forecast | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker today reported that revenues for its second quarter increased 5 percent year over year as the company missed the consensus Wall Street estimate on the top and bottom line.

For the three months ended June 30, Bruker posted revenues of $420.7 million, up from the year-ago figure of $401.2 million, but short of the average analyst estimate of $425 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.